Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. More Details
Reasonable growth potential with adequate balance sheet.
Share Price & News
How has Protech Home Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PTQ's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PTQ exceeded the Canadian Healthcare industry which returned -7.7% over the past year.
Return vs Market: PTQ exceeded the Canadian Market which returned -5.5% over the past year.
Price Volatility Vs. Market
How volatile is Protech Home Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StHealth Check: How Prudently Does Protech Home Medical (CVE:PTQ) Use Debt?
1 month ago | Simply Wall StProtech Home Medical Corp.'s (CVE:PTQ) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
4 months ago | Simply Wall StThe Protech Home Medical (CVE:PTQ) Share Price Has Gained 83% And Shareholders Are Hoping For More
Is Protech Home Medical undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: PTQ (CA$1.56) is trading above our estimate of fair value (CA$0.35)
Significantly Below Fair Value: PTQ is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: PTQ is poor value based on its PE Ratio (180.1x) compared to the CA Healthcare industry average (67.9x).
PE vs Market: PTQ is poor value based on its PE Ratio (180.1x) compared to the Canadian market (16x).
Price to Earnings Growth Ratio
PEG Ratio: PTQ is poor value based on its PEG Ratio (3.1x)
Price to Book Ratio
PB vs Industry: PTQ is overvalued based on its PB Ratio (3.8x) compared to the CA Healthcare industry average (2.7x).
How is Protech Home Medical forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PTQ's forecast earnings growth (57.5% per year) is above the savings rate (1.7%).
Earnings vs Market: PTQ's earnings (57.5% per year) are forecast to grow faster than the Canadian market (22.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PTQ's revenue (10.9% per year) is forecast to grow faster than the Canadian market (5.8% per year).
High Growth Revenue: PTQ's revenue (10.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PTQ's Return on Equity is forecast to be high in 3 years time
How has Protech Home Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PTQ has a large one-off gain of CA$7.4M impacting its June 30 2020 financial results.
Growing Profit Margin: PTQ became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: PTQ has become profitable over the past 5 years, growing earnings by 20.7% per year.
Accelerating Growth: PTQ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PTQ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (17.2%).
Return on Equity
High ROE: PTQ's Return on Equity (2.1%) is considered low.
How is Protech Home Medical's financial position?
Financial Position Analysis
Short Term Liabilities: PTQ's short term assets (CA$66.9M) exceed its short term liabilities (CA$30.1M).
Long Term Liabilities: PTQ's short term assets (CA$66.9M) exceed its long term liabilities (CA$21.3M).
Debt to Equity History and Analysis
Debt Level: PTQ's debt to equity ratio (33.8%) is considered satisfactory.
Reducing Debt: PTQ's debt to equity ratio has increased from 4.3% to 33.8% over the past 5 years.
Debt Coverage: PTQ's debt is well covered by operating cash flow (208.1%).
Interest Coverage: Insufficient data to determine if PTQ's interest payments on its debt are well covered by EBIT.
What is Protech Home Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PTQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PTQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PTQ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PTQ's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PTQ's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Gregory J. Crawford also known as Greg, has been Chief Executive Officer, President and Director of Protech Home Medical Corp. (also known as Patient Home Monitoring Corp.) ("PHM") since December 21, 2 ...
CEO Compensation Analysis
Compensation vs Market: Greg's total compensation ($USD863.74K) is above average for companies of similar size in the Canadian market ($USD170.92K).
Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.
|Chief Financial Officer||2.67yrs||CA$556.32k||no data|
|Vice President of Operations||no data||no data||no data|
|Vice President of Technology||no data||no data||no data|
|Chief Strategy Officer & Investor Relations||no data||CA$308.24k||no data|
|Executive Vice President of Business Development||9.42yrs||no data||no data|
|Chief Medical Officer||5yrs||no data||no data|
|Executive Vice President of Finance||1.08yrs||no data||no data|
|Corporate Secretary||8.75yrs||no data||no data|
Experienced Management: PTQ's management team is considered experienced (3.9 years average tenure).
|Independent Director||2.83yrs||CA$120.00k||0.052% |
|Independent Non-Executive Director||2.17yrs||CA$50.00k||0.25% |
|Member of the Board of Advisors||7yrs||no data||no data|
|Member of the Board of Advisors||7yrs||no data||no data|
Experienced Board: PTQ's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.9%.
Protech Home Medical Corp.'s company bio, employee growth, exchange listings and data sources
- Name: Protech Home Medical Corp.
- Ticker: PTQ
- Exchange: TSXV
- Founded: 1993
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$174.478m
- Shares outstanding: 111.84m
- Website: https://www.protechhomemedical.com
- Protech Home Medical Corp.
- 1019 Town Drive
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PTQ||TSXV (TSX Venture Exchange)||Yes||New Common Shares||CA||CAD||Dec 2017|
|A2PBDH||DB (Deutsche Boerse AG)||Yes||New Common Shares||DE||EUR||Dec 2017|
|PTQQ.F||OTCPK (Pink Sheets LLC)||Yes||New Common Shares||US||USD||Dec 2017|
Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP ma ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/28 23:49|
|End of Day Share Price||2020/10/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.